Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F23V1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,722
Award facts
- Contract value 100% obligated
- $21,721.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $21,721.88 and an ultimate completion date of December 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen serves the Defense Health Agency and other military healthcare systems through its comprehensive pharmaceutical supply agreements. Dupixent (dupilumab) is a specialty biologic medication used to treat conditions such as moderate-to-severe atopic dermatitis and eosinophilic asthma, making this delivery order part of the company's broader portfolio of specialty medications supplied to support military and federal healthcare programs. The short completion window reflects the urgent nature of pharmaceutical supply requirements within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F23V1?
SPE2DR26F23V1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F23V1 worth?
The government has obligated $21,722 on SPE2DR26F23V1.
Is contract SPE2DR26F23V1 an order under another contract?
Yes. SPE2DR26F23V1 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23V1 competed?
The extent of competition for SPE2DR26F23V1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award